Medicine News and Research

RSS

AMT announces full year 2009 results; reports modest decrease in operating expenses

Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, today reported its results for the year to December 31, 2009.

24 Feb 2010

Medical innovation: A real boon for American patients

An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research.

24 Feb 2010

GW report: Asthma is on the rise in America and more than 1M children with asthma not insured

Researchers from The George Washington University, School of Public Health and Health Services said today that asthma, a largely manageable and chronic disease, is on the rise in America and released new data on the magnitude of the asthma crisis, the surging cost of treatment, and the more than 1 million children with asthma who are uninsured.

24 Feb 2010

Study says lower-cost hospitals don't have lower quality care for certain illnesses

A study Monday in the Archives of Internal Medicine found little difference in outcomes between hospitals with longer patient stays and shorter ones, which could make it "possible to lower costs in the U.S. system without hurting patients," Reuters reports.

24 Feb 2010

Study may help in defining better therapeutic strategies for oral and throat cancer

Mayo Clinic researchers along with collaborators from Life Technologies are reporting on the application of a new approach for sequencing RNA to study cancer tumors. Their findings from a proof-of-principle study on oral carcinomas appear in the current issue of PLoS One, the online science journal.

24 Feb 2010

New genetic data may help predict risk for end-stage kidney disease

Israeli and American researchers have identified new genetic data that could be used in the future to predict who will develop end-stage kidney disease (ESKD). ESKD requires dialysis or transplantation to sustain life, and is fatal in most regions of the world, where these treatments are not available.

24 Feb 2010

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, has joined the Personalized Medicine Coalition, an educational and advocacy group dedicated to advancing the understanding and adoption of personalized medicine, defined as the application of genomic and molecular data to better target the delivery of healthcare by determining a person's predisposition to a particular disease or condition.

24 Feb 2010

Prednisolone associated with recurrence of CAP after its withdrawal

Patients hospitalized with mild to moderate community-acquired pneumonia (CAP) should not be routinely prescribed prednisolone, a corticosteroid, as it is associated with a recurrence of symptoms after its withdrawal, according to the first randomized double-blind clinical trial to address the subject.

24 Feb 2010

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

SRI International, an independent nonprofit research and development institute, has received a $3.8M contract from the Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). SRI will research and develop a device to triage individuals who may have been exposed to ionizing radiation after a radiological or nuclear incident.

24 Feb 2010

Clout of drug industry seen in MD residency programs and in health reform

News outlets report on the pharmaceutical industry's involvement in doctor training and its role in shaping the health care overhauls pending in Congress.

24 Feb 2010

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

Longhorn Vaccines & Diagnostics today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ in CLIA high complexity laboratories. . The Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay™ is a ready-use assay that requires no mixing prior to use and has been authorized for use on the ABI 7500.

24 Feb 2010

Enrollment complete in Ocera Therapeutics' ASTUTE Phase 2B trial for mild hepatic encephalopathy

Ocera Therapeutics, Inc. announced today that the ASTUTE Study (AST-120 Used to Treat Hepatic Encephalopathy) has completed enrollment for its Phase 2B study ahead of schedule, with data expected mid 2010.

24 Feb 2010

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231 (P-tau231), a damaged tau protein found in patients with Alzheimer's disease, may be an early diagnostic biomarker for Alzheimer's disease in healthy adults.

23 Feb 2010

New Barts Cancer Research UK Centre launched

A new cancer centre, launched today, puts London at the forefront of cancer research.

23 Feb 2010

Medco Health Solutions announces record 16.7% increase in total net revenues for 2009

Medco Health Solutions, Inc. today reported record fourth-quarter 2009 GAAP diluted earnings per share of $0.70, up 29.6 percent compared to $0.54 in fourth-quarter 2008. Excluding the amortization of intangible assets that existed when Medco became a publicly traded company in 2003, fourth-quarter 2009 diluted earnings per share increased 28.8 percent to a record $0.76. Medco also reported record full-year 2009 GAAP diluted earnings per share of $2.61, up 22.5 percent -- exceeding the high-end of the company's guidance.

23 Feb 2010

First Edition: February 23, 2010

Today's headlines focus on President Obama's revamped health reform proposal, what it includes and how Democrats, Republicans and the insurers are reacting to it.

23 Feb 2010

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

A new report identifies the enormous global impact of preterm birth and stillbirth—and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000. Additionally, an estimated 3.2 million are stillborn each year, and many of these losses are linked to maternal deaths.

23 Feb 2010

Key mechanism that makes brain cells become tumorous identified

Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.

23 Feb 2010

Slightly to moderately elevated CRP levels in patients undergoing CABG surgery: Implications

A new study published in the March issue of Anesthesiology raises awareness for an additional risk category for patients undergoing routine coronary artery bypass surgery - low to moderate levels of inflammation.

23 Feb 2010

Strategies to reduce inappropriate treatment by clinicians

Clinicians may use one of several approaches to deny patient requests for an inappropriate treatment while preserving the physician-patient relationship, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 Feb 2010

Medicine News and Research

AMT announces full year 2009 results; reports modest decrease in operating expenses

Medical innovation: A real boon for American patients

GW report: Asthma is on the rise in America and more than 1M children with asthma not insured

Study says lower-cost hospitals don't have lower quality care for certain illnesses

Study may help in defining better therapeutic strategies for oral and throat cancer

New genetic data may help predict risk for end-stage kidney disease

XIFIN joins PMC to help evolve reimbursement policies and practices that support personalized medicine

Prednisolone associated with recurrence of CAP after its withdrawal

SRI International awarded $3.8M BARDA contract to develop a radiation assessment device

Clout of drug industry seen in MD residency programs and in health reform

FDA grants EUA for Longhorn Influenza A/H1N1-09 Prime RRT-PCR Assay in CLIA high complexity laboratories

Enrollment complete in Ocera Therapeutics' ASTUTE Phase 2B trial for mild hepatic encephalopathy

Elevated cerebrospinal fluid levels of P-tau231 may be an early diagnostic biomarker for Alzheimer's disease

New Barts Cancer Research UK Centre launched

Medco Health Solutions announces record 16.7% increase in total net revenues for 2009

First Edition: February 23, 2010

Prevention of preterm birth and stillbirth: Global collaborative efforts needed

Key mechanism that makes brain cells become tumorous identified

Slightly to moderately elevated CRP levels in patients undergoing CABG surgery: Implications

Strategies to reduce inappropriate treatment by clinicians

Everything there is to know about biosimilars eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News